SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-013118
Filing Date
2020-01-23
Accepted
2020-01-23 16:29:50
Documents
6
Effectiveness Date
2020-01-23

Document Format Files

Seq Description Document Type Size
1 S-8 d876082ds8.htm S-8 80669
2 EX-5.1 d876082dex51.htm EX-5.1 5177
3 EX-23.1 d876082dex231.htm EX-23.1 1483
4 EX-99.1 d876082dex991.htm EX-99.1 207381
5 EX-99.3 d876082dex993.htm EX-99.3 114725
6 GRAPHIC g876082page77.jpg GRAPHIC 3284
  Complete submission text file 0001193125-20-013118.txt   415125
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236042 | Film No.: 20542489
SIC: 2834 Pharmaceutical Preparations